BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
A Alu, H Lei, X Han, Y Wei, X Wei - Journal of Hematology & Oncology, 2022 - Springer
Bruton's tyrosine kinase (BTK) is an essential component of multiple signaling pathways that
regulate B cell and myeloid cell proliferation, survival, and functions, making it a promising …
regulate B cell and myeloid cell proliferation, survival, and functions, making it a promising …
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
JA Burger, A Wiestner - Nature Reviews Cancer, 2018 - nature.com
B cell receptor (BCR) signalling is crucial for normal B cell development and adaptive
immunity. BCR signalling also supports the survival and growth of malignant B cells in …
immunity. BCR signalling also supports the survival and growth of malignant B cells in …
Targeting pathological B cell receptor signalling in lymphoid malignancies
Signalling through the B cell receptor (BCR) is central to the development and maintenance
of B cells. In light of the numerous proliferative and survival pathways activated downstream …
of B cells. In light of the numerous proliferative and survival pathways activated downstream …
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
A Agathangelidis, N Darzentas… - Blood, The Journal …, 2012 - ashpublications.org
Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into
distinct subsets with stereotyped BCRs is functionally and prognostically relevant. However …
distinct subsets with stereotyped BCRs is functionally and prognostically relevant. However …
Chronic lymphocytic leukaemia
L Scarfò, AJM Ferreri, P Ghia - Critical reviews in oncology/hematology, 2016 - Elsevier
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among the adults in
the Western World. CLL (and the corresponding nodal entity small lymphocytic lymphoma …
the Western World. CLL (and the corresponding nodal entity small lymphocytic lymphoma …
Pathogenesis of human B cell lymphomas
AL Shaffer III, RM Young… - Annual review of …, 2012 - annualreviews.org
The mechanisms that drive normal B cell differentiation and activation are frequently
subverted by B cell lymphomas for their unlimited growth and survival. B cells are …
subverted by B cell lymphomas for their unlimited growth and survival. B cells are …
From pathogenesis to treatment of chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia (CLL) has several unique features that distinguish it from
other cancers. Most CLL tumour cells are inert and arrested in G0/G1 of the cell cycle and …
other cancers. Most CLL tumour cells are inert and arrested in G0/G1 of the cell cycle and …
B‐cell receptor signalling and its crosstalk with other pathways in normal and malignant cells
The physiology of B cells is intimately connected with the function of their B‐cell receptor
(BCR). B‐cell lymphomas frequently (dys) regulate BCR signalling and thus take advantage …
(BCR). B‐cell lymphomas frequently (dys) regulate BCR signalling and thus take advantage …
The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies
JA Burger, JG Gribben - Seminars in cancer biology, 2014 - Elsevier
Over the last decade, the active role of the microenvironment in the pathogenesis of B cell
lymphomas has been recognized, delivering signals that favor clonal expansion and drug …
lymphomas has been recognized, delivering signals that favor clonal expansion and drug …
Cellular origin and pathophysiology of chronic lymphocytic leukemia
M Seifert, L Sellmann, J Bloehdorn, F Wein… - Journal of Experimental …, 2012 - rupress.org
The cellular origin of chronic lymphocytic leukemia (CLL) is still debated, although this
information is critical to understanding its pathogenesis. Transcriptome analyses of CLL and …
information is critical to understanding its pathogenesis. Transcriptome analyses of CLL and …